Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques

<div>QSDH drug formulary active ingredients-intersectiontarget-disease network. (Red triangles represent diseases, blue rectangles represent active ingredients, and yellow ellipses represent intersection targets).</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques 

Figure 4 | Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques 